← Leaderboards
Mary Chester M. Wasko
University Of Pittsburgh At Pittsburgh
$655,805
Attributed
$655,805
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$655,805 · 5
By mechanism
K23$618,570 · 1
M01$37,235 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- James John Irrgang$5,270,248
- Debra Kaye Weiner$3,397,320
- Said A. Ibrahim$6,876,464
- Kang Kim$11,352,976
- Volker Musahl$1,589,781
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectRheumatoid ArthritisCardiovascular DisorderClinical ResearchFemaleMyocardial InfarctionCongestive Heart FailureCardiovascular Disorder EpidemiologyCarotid ArteryPathologic ProcessSystemic Lupus ErythematosusDisease /Disorder Proneness /RiskStatistics /BiometryYoung Adult Human (21-34)Antiarthritic AgentAtherosclerosisAtherosclerotic PlaqueComputed Axial TomographyData ManagementDrug Screening /EvaluationHuman Therapy EvaluationMethotrexateNoninvasive DiagnosisNonsteroidal Antiinflammatory Agent
Grant awards (13)
Cardiovascular Disease in Rheumatoid Arthritis$123,714
K23 · FY2005 · AR
TOWARD IMPROVING LONG TERM OUTCOMES IN ARTHRITIS: ARAMIS 2006$12,324
M01 · FY2005 · RR
Cardiovascular Disease in Rheumatoid Arthritis$123,714
K23 · FY2004 · AR
Epidemiology of Cardiovascular Disease in Women with RA$10,430
M01 · FY2004 · RR
Toward Improving Long Term Outcomes in Arthritis$8,903
M01 · FY2004 · RR
Vascular Disease in Women with Rheumatoid Arthritis$2,544
M01 · FY2004 · RR
Cardiovascular Disease in Rheumatoid Arthritis$123,714
K23 · FY2003 · AR
Cardiovascular Disease in Rheumatoid Arthritis$123,714
K23 · FY2002 · AR
PHASE III STUDY COMPARING TNFR--FC TO METHOTREXATEXT IN RHEUMATOID ARTHRITIS$0
M01 · FY2002 · RR
PHASE III STUDY COMPARING TNFR--FC TO METHOTREXATEXT IN RHEUMATOID ARTHRITIS$0
M01 · FY2002 · RR
Cardiovascular Disease in Rheumatoid Arthritis$123,714
K23 · FY2001 · AR
PHASE III STUDY COMPARING TNFR--FC TO METHOTREXATEXT IN RHEUMATOID ARTHRITIS$0
M01 · FY2001 · RR
PHASE III STUDY COMPARING TNFR--FC TO METHOTREXATEXT IN RHEUMATOID ARTHRITIS$3,034
M01 · FY2000 · RR